Skip to main content

Hana Moran, Friedman, Billings, Ramsey & Co.


Nuvelo has appointed Hana Moran vice president of regulatory affairs and quality assurance.

Moran comes to Nuvelo from Lipid Sciences, where she was vice president of regulatory affairs and quality assurance. Before that she held senior management positions at BioMedicines and SangStat Medical Corp.

Lynx Therapeutics has hired Friedman, Billings, Ramsey & Co. to be its financial advisor. In April 2002, FBR acted as sole manager for an approximately $22.6 million private financing of common stock and warrants for common stock for the struggling gene-expression shop.

“We’ve engaged FBR to help us consider opportunities that may be presented to us,” said Kevin Corcoran, Lynx’s president and CEO. “We believe that our Massively Parallel Signature Sequencing services and related products are poised for significant growth in the gene expression market.”

Filed under

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.